Xuejun Liu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xuejun liu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xuejun Liu Today - Breaking & Trending Today

I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023

I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics, today announced that two poster presentations featuring preclinical data on givastomig (also known as TJ-CD4B/ABL111) and TJ-L14B/ABL503, the Company's 4-1BB-targeting bispecific antibody assets, will be reported at the 38th Society for Immunotherapy o ....

South Korea , Xuejun Liu , Jaeho Jung , Tyler Ehler , Bio Kosdaq , Gigi Feng , Drug Administration , Exchange Commission , Orphan Drug Designation , Private Securities Litigation Reform Act , Bispecific Antibody , Gastric Cancer , Poster Presentations , I Mab ,

I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI and GAITHERSBURG, Md., March 9, 2022 /PRNewswire/ I-Mab (the Company ) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company com. ....

United States , Hong Kong , San Diego , Xuejun Liu , Andrew Zhu , Jian Li , Exchange Commission , American Association For Cancer Research , Prnewswire The Company Nasdaq , American Association , Cancer Research , Both Innate , Adaptive Immunity , Novel Claudin , Private Securities Litigation Reform Act ,